|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed-maturity securities, available-for-sale, at fair value, net of allowance for credit loss of $72 and $54 (amortized cost of $7,147 and $6,572) | ||||||||||||||||||||
| Fixed-maturity securities, trading, at fair value | ||||||||||||||||||||
| Short-term investments, at fair value | ||||||||||||||||||||
| Other invested assets (includes $3 and $3, at fair value) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Premiums receivable, net of commissions payable, net of allowance for credit losses of $7 and $3 | ||||||||||||||||||||
| Funds withheld, at fair value | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Salvage and subrogation recoverable | ||||||||||||||||||||
| Financial guaranty variable interest entities’ assets (includes $164 and $172, at fair value) | ||||||||||||||||||||
| Assets of consolidated investment vehicles (includes $– and $167, at fair value) | ||||||||||||||||||||
| Goodwill and other intangible assets | ||||||||||||||||||||
| Other assets (includes $187 and $174, at fair value) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Unearned premium reserve | ||||||||||||||||||||
| Loss and loss adjustment expense reserve | ||||||||||||||||||||
| Future policy benefits for annuity reinsurance contracts | ||||||||||||||||||||
| Policyholder account balances for annuity reinsurance contracts | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Credit derivative liabilities, at fair value | ||||||||||||||||||||
| Financial guaranty variable interest entities’ liabilities with recourse, at fair value | ||||||||||||||||||||
| Financial guaranty variable interest entities’ liabilities without recourse, at fair value | ||||||||||||||||||||
| Financial guaranty variable interest entities’ liabilities, at fair value (with recourse $153 and $155, without recourse $10 and $9) | ||||||||||||||||||||
| Liabilities of consolidated investment vehicles (includes $0 and $4,431, at fair value) | ||||||||||||||||||||
| Financial guaranty variable interest entities’ liabilities (includes $147 and $197, at fair value, $172 and $182 with recourse, $16 and $16 without recourse) | ||||||||||||||||||||
| Other liabilities (includes $27 and $21, at fair value) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common shares ($0.01 par value, 500,000,000 shares authorized; 44,055,227 and 45,184,791 shares issued and outstanding) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax of $(55) and $(39) | ||||||||||||||||||||
| Deferred equity compensation | ||||||||||||||||||||
| Total shareholders’ equity attributable to Assured Guaranty Ltd. | ||||||||||||||||||||
| Non-redeemable noncontrolling interest (Note 10) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
